Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Filings indexed 674 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance report for the Year Ended 31st March, 2026
Regulatory Filings Classification · 88% confidence The document is a Secretarial Compliance Report under SEBI LODR Regulations, signed by the Practicing Company Secretary, certifying compliance with listing obligations. It is an officer certification/attestation rather than a financial report (10-K/IR) or a management presentation. Under the CERTIFICATION RULE, such compliance certificates fall under Regulatory Filings (RNS) as a general regulatory submission and fallback category.
2026-05-26 English
JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Audited Financial ....
Regulatory Filings Classification · 85% confidence The document is a formal intimation under SEBI LODR Regulation 29 notifying stock exchanges of a scheduled Board meeting to consider and approve audited financial results. It does not contain any financial statements itself nor announce the publication of a report, nor report a change in board composition. This is a regulatory/compliance announcement and falls under the catch-all “Regulatory Filings” category (RNS).
2026-05-20 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 87% confidence The document is a statutory disclosure under SEBI SAST Regulations (Regulation 31) reporting that promoters have not created any encumbrances on their shares. It is a compliance/regulatory filing rather than an annual report, earnings release, shareholding change, or other defined report type. The content does not reflect a change in shareholding thresholds (MRQ), nor is it a financial statement, proxy statement, or director dealing notice. Therefore it falls into the fallback category of Regulatory Filings (RNS).
2026-05-19 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document is a statutory disclosure under SEBI Regulation 31(4) regarding promoter group encumbrances on shares. It is not a financial report, not announcing dividend or voting results, not a management/board change notice, and contains no substantive financial data. This is a regulatory compliance filing and falls under the general Regulatory Filings category (RNS).
2026-05-19 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange India Limited clarifying a discrepancy in previously submitted financial results and EPS figures. It mentions that revised Integrated Financial Results for the quarter ended September 2025 were filed to rectify the discrepancies. The document is short (1575 characters) and serves as a clarification and notification of a revised filing rather than containing actual financial data or detailed financial statements. It does not present the financial results itself but refers to a revised submission. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance communications that do not fit other specific categories.
2026-05-08 English
Registrar & Share Transfer Agent Update
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding a change in the company's Registrar & Share Transfer Agent (RTA). It references compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, and provides details about the new RTA. The document is a notification of a corporate action related to administrative changes rather than a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or voting results. It is a regulatory announcement about a change in company service providers, fitting best under general regulatory announcements. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is short and it is not a report publication announcement or certification letter, so RNS is the best fit with high confidence.
2026-04-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.